After hip or knee replacement, aspirin failed to show non-inferiority to rivaroxaban or warfarin for preventing death or symptomatic clots (1.26% vs 0.94% and 1.23%). The anticoagulants in turn did not match aspirin on safety.
RCTn = 18,883
Pellegrini et al. Prevention of Venous Thromboembolism after Total Hip or Knee Replacement